Ethical Perspectives
In this section:
- The legality of fixing genetic disorders in embryos
- Issues and ethics of human embryos generated from reprogrammed cells
- U.S. Businesses using ClinicalTrials.gov to market unproven and unlicensed stem cell interventions
- Whose cells are they? Public perceptions about owning autologous cells
- Navigating ethics in the large grey zone of unproven stem cell treatments
- Setting straight perspectives on stem cell tourism